Cutler Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-100
| Closed | -$5K | – | 2304 |
|
|
2022
Q2 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 1535 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2497 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2226 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1965 |
|
|
2019
Q2 | – | Sell |
-1,000
| Closed | -$38K | – | 2040 |
|
|
2019
Q1 | $38K | Buy |
+1,000
| New | +$38K | ﹤0.01% | 906 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2033 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2034 |
|
|
2018
Q2 | – | Sell |
-2,700
| Closed | -$84K | – | 2110 |
|
|
2018
Q1 | $84K | Sell |
2,700
-5,193
| -66% | -$162K | 0.01% | 793 |
|
|
2017
Q4 | $360K | Sell |
7,893
-3,640
| -32% | -$166K | 0.01% | 467 |
|
|
2017
Q3 | $433K | Buy |
11,533
+9,957
| +632% | +$374K | 0.02% | 487 |
|
|
2017
Q2 | $75K | Sell |
1,576
-8,541
| -84% | -$406K | ﹤0.01% | 1307 |
|
|
2017
Q1 | $461K | Sell |
10,117
-12,523
| -55% | -$571K | 0.02% | 499 |
|
|
2016
Q4 | $731K | Buy |
22,640
+7,780
| +52% | +$251K | 0.03% | 367 |
|
|
2016
Q3 | $508K | Buy |
+14,860
| New | +$508K | 0.02% | 385 |
|
|
2016
Q2 | – | Sell |
-1,956
| Closed | -$103K | – | 3221 |
|
|
2016
Q1 | $103K | Sell |
1,956
-3,885
| -67% | -$205K | 0.01% | 926 |
|
|
2015
Q4 | $448K | Buy |
+5,841
| New | +$448K | 0.03% | 420 |
|